Sitemap

• Welcome to singular mAb experience
• SYnAbs Top 10 monoclonal antibodies
• Immunoassays provider
• • MYstick, mouse isotyping kit
  • Residual protein A
  • Immunoaffinity columns
• Secondary monoclonal antibodies
• • Secondary monoclonal antibodies : Anti-mouse Ig
  • Secondary monoclonal antibodies : Anti-rat Ig
  • Secondary monoclonal antibodies : Anti-human Ig
  • Secondary monoclonal antibodies : Anti-rabbit mAbs
  • Secondary monoclonal antibodies : Anti-species mAbs
• Primary monoclonal antibodies
• • Primary monoclonal antibodies : Irrelevant Ig anti-DNP
  • Primary monoclonal antibodies : Isotype control Ig
  • Primary monoclonal antibodies : Anti-toxins mAbs
  • Primary monoclonal antibodies : Anti-pathogens mAbs
  • Primary monoclonal antibodies : Anti-HRP, FITC, Biotin & Quenchers conjugates
  • Primary monoclonal antibodies : Anti-cytokines & hormones
  • Primary monoclonal antibodies : Anti-proteins
  • Primary monoclonal antibodies : Anti-chemical compounds
• Custom monoclonal antibody development
• Rat Monoclonal Antibodies
• • High sensitivity anti-Aflatoxin mAbs
  • Unique mAbs targeting DNA epigenetic modifications
  • Therapeutic anti-IL34 mAbs
  • Unique mAbs targeting peptide biomarkers
  • Singular mAbs for infectious diseases antigens
  • High affinity mAbs against steroids
• Guinea pig Monoclonal Antibodies
• About SynAbs
• • SynAbs recent news
  • • Distribution agreement
    • Congress
    • Organic growth
    • Technical breakthrough
  • A team of mAb experts
  • Distributors of SynAbs mAbs catalogue
  • Partners for one-stop-shop mAb solution
  • Contact SynAbs

Blog

• 10/01/2018 - SYnAbs enters in Italy!
• 08/28/2018 - SYnAbs is proud to announce ISO 9001:2015 certification!
• 08/04/2018 - SYnAbs attended AACC congress in Chicago! Great success!
• 07/27/2018 - SYnAbs enters Chinese market!
• 06/25/2018 - SYnAbs is looking for new talents to expand its cell culture team
• 06/19/2018 - SYnAbs attended Pivotal Congress in Oxford
• 02/06/2018 - SYnAbs attended Buzz4Bio Cell&Gene Therapies
• 02/01/2018 - SYnAbs attended Innovation for Health in Rotterdam
• 01/24/2018 - SYnAbs launches mouse isotyping kit, MYstik™
• 01/24/2018 - SynAbs inks agreement with SKLM as new distributor for its unique catalogue of monoclonal antibodies in Morocco
• 01/17/2018 - SynAbs inks agreement with Theranostica as new distributor for its unique catalogue of monoclonal antibodies in Israël
• 12/14/2017 - SYnAbs/RD Biotech unique expertise in CAR-T cells
• 11/27/2017 - SynAbs, from UCL benches to Singapore
• 11/20/2017 - SynAbs attended Medica congress in Dusseldorf, Germany
• 10/24/2017 - SynAbs inks first distribution agreement in Asia
• 09/05/2017 - SynAbs widens its team to sustain organic growth
• 06/21/2017 - SynAbs attended Pivotal Scientific congress in Oxford!
• 06/01/2017 - SynAbs moves its facilities to Gosselies BioPark
• 05/24/2017 - SynAbs attended BioMed congress in Israël!
• 05/18/2017 - SynAbs attended Knowledge for Growth event in Ghent!
• 05/10/2017 - SynAbs attended WBC 10th anniversary as special guest!
• 05/05/2017 - SynAbs inks agreement with Sapphire as new distributor for its unique catalogue of monoclonal antibodies in USA & Canada
• 01/13/2017 - SynAbs inks agreement with Dianova GmbH as new distributor for its unique catalogue of monoclonal antibodies in Germany
• 09/19/2016 - SynAbs appoints LuBioScience GmbH as new distributor for its unique catalogue of monoclonal antibodies in Switzerland
• 08/03/2016 - Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics
• 08/03/2016 - The small molecule detection challenge : the aflatoxin case study
• 01/28/2016 - SynAbs brings rats to antibody market
• 09/01/2015 - SynAbs set-up, a new rat mAb expert on the marketplace